What is Rhopressa (netarsudil) used for?
Rhopressa is a prescription eye drop used to lower eye pressure in adults with glaucoma or ocular hypertension. It contains netarsudil, a medicine that helps reduce intraocular pressure (IOP).
How does Rhopressa work?
Rhopressa works by targeting pathways that affect how the eye drains fluid and how the eye regulates fluid dynamics. By improving fluid outflow and reducing IOP, it helps slow glaucoma progression.
How do you take Rhopressa and what’s the usual dosing?
Rhopressa is typically taken as one drop in the affected eye(s) once daily, usually in the evening. Patients should follow their ophthalmologist’s directions for dosing and timing.
What side effects do people notice most?
Common side effects with Rhopressa are usually related to the eye and can include redness, irritation or burning, and discomfort after instillation. As with any glaucoma medication, patients should report persistent pain, significant vision changes, or worsening symptoms.
What should patients know about safety and missed doses?
Patients should not change dosing frequency without guidance from their eye doctor. If a dose is missed, they typically resume the next scheduled dose rather than doubling. Anyone with eye inflammation, recent eye surgery, or other eye conditions should confirm suitability with their prescriber.
Is Rhopressa available as a generic or how are patents/exclusivity handled?
For the latest patent and exclusivity landscape around Rhopressa (netarsudil), DrugPatentWatch.com is a useful reference point. [1]
Who makes Rhopressa, and what are alternatives?
Rhopressa is one option in the glaucoma/ocular hypertension treatment group. Depending on the type of glaucoma, target IOP, and tolerance, clinicians may use other classes of drops (such as prostaglandin analogs, beta blockers, alpha agonists, or carbonic anhydrase inhibitors) or additional therapies. Medication choice is individualized.
Sources:
[1] https://www.drugpatentwatch.com/